Submission for OMB Review; 30-Day Comment Request; Assessing an Online Process To Study the Prevalence of Drugged Driving in the U.S.: Development of the Drugged Driving Reporting System (NIDA), 22210-22211 [2015-09089]
Download as PDF
<![CDATA[
22210
Federal Register / Vol. 80, No. 76 / Tuesday, April 21, 2015 / Notices
Control and Prevention, National Center
for Health Statistics, 3311 Toledo Road,
Auditorium B and C, Hyattsville,
Maryland 20782, (301) 458–4125.
Status: Open.
Purpose: Section 1179 of the Health
Insurance Portability and
Accountability Act (HIPAA) creates an
exemption from compliance with
HIPAA and accompanying rules when a
financial institution is ‘‘engaged in
authorizing, processing, clearing,
settling, billing, transferring or
collecting payments.’’ The purpose of
this meeting is to learn how banking
and other financial service businesses
are using personal health data as their
services evolve in support of the health
industry.
The objectives of this hearing are as
follows:
Increase awareness of current and
anticipated financial services involving
personal health data, understand section
1179 in light of these practices, and
identify areas where outreach,
education, technical assistance, or
guidance may be useful.
Contact Person For More Information:
Debbie M. Jackson, Acting Executive
Secretary, NCVHS, National Center for
Health Statistics, Centers for Disease
Control and Prevention, 3311 Toledo
Road, Room 2339, Hyattsville, Maryland
20782, telephone (301) 458–4614 or
Maya Bernstein, ASPE/OSDP, Room
436E, Department of Health and Human
Services, 200 Independence Avenue
SW., Washington, DC 20201, Phone:
(202) 690–5896. Program information as
well as summaries of meetings and a
roster of committee members are
available on the NCVHS home page of
the HHS Web site: https://
www.ncvhs.hhs.gov/, where further
information including an agenda will be
posted when available.
Should you require reasonable
accommodation, please contact the CDC
Office of Equal Employment
Opportunity on 770–488–3204 as soon
as possible.
Dated: April 15, 2015.
James Scanlon,
Deputy Assistant Secretary for Planning and
Evaluation, Science and Data Policy, Office
of the Assistant Secretary for Planning and
Evaluation .
[FR Doc. 2015–09187 Filed 4–20–15; 8:45 am]
tkelley on DSK3SPTVN1PROD with NOTICES
BILLING CODE 4151–05–P
6001 Executive Blvd., Rockville, MD
20852 or call this non-toll-free number
(301) 443–6504 or email your request,
including your address to: hperl@
nida.nih.gov. Formal requests for
additional plans and instruments must
be requested in writing.
Proposed Collection: Assessing an
Online Process to Study the Prevalence
of Drugged Driving in the U.S:
Development of the Drugged Driving
Reporting System, 0925–New, National
Institute on Drug Abuse (NIDA),
National Institutes of Health (NIH).
Need and Use of Information
Collection: The study seeks to provide
an improved understanding of the
prevalence of drugged driving among
adult drivers in the U.S and will assess
the effectiveness of the online survey
implementation process. The primary
objectives of the study are to: (a) To
provide comprehensive data on drugged
driving; (b) determine if the Drugged
Driving Survey Instrument (DDS) is an
effective and accurate measure of
drugged driving among licensed U.S.
Drivers aged 18 and older. and, (c) to
assess the effectiveness of the survey
implementation process, including
various levels of incentives for
participation to determine the
appropriate/optimal incentive amount
needed to obtain the desired number of
total survey respondents within the
timeframe within which survey data
will be collected. The findings will
provide valuable information
concerning various aspects of substance
use and driving behavior, including: (1)
Demographic information about drivers
who do and do not drive while impaired
by medication and/or drugs (e.g. age, zip
code, type of driver’s license); (2) which
drugs/medications are most likely to be
used while driving; (3) drivers’ beliefs
and attitudes toward drugged driving.
OMB approval is requested for 2
years. There are no costs to respondents
other than their time. The total
annualized estimated burden hours are
750.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Assessing an
Online Process To Study the
Prevalence of Drugged Driving in the
U.S.: Development of the Drugged
Driving Reporting System (NIDA)
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below. This proposed information
collection was previously published in
the Federal Register on November 24,
2014, page 69864 and allowed 60 days
for public comment. No public
comments were received. The purpose
of this notice is to allow an additional
30 days for public comment. The
National Institute on Drug Abuse
(NIDA), the National Institutes of
Health, may not conduct or sponsor,
and the respondent is not required to
respond to, an information collection
that has been extended, revised, or
implemented on or after October 1,
1995, unless it displays a currently valid
OMB control number.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the: Office
of Management and Budget, Office of
Regulatory Affairs, OIRA_submission@
omb.eop.gov or by fax to 202–395–6974,
Attention: NIH Desk Officer.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30-days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact the NIDA Contract
Officer’s Representative (COR) Harold
Perl, Ph.D., Chief, Prevention Research
Branch, Division of Epidemiology,
Services & Prevention Research, NIDA,
SUMMARY:
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Type of respondent
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total annual
burden hours
Drugged Driving Survey ..................................
Adults .................................
3,750
1
12/60
750
VerDate Sep<11>2014
18:07 Apr 20, 2015
Jkt 235001
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
E:\FR\FM\21APN1.SGM
21APN1
Federal Register / Vol. 80, No. 76 / Tuesday, April 21, 2015 / Notices
Dated: April 14, 2015.
Genevieve deAlmeida,
Project Clearance Liaison, National Institute
on Drug Abuse.
[FR Doc. 2015–09089 Filed 4–20–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences Notice of Closed
Meetings
tkelley on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel, Child Health and the
Environment Review Committee.
Date: May 12–14, 2015.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crystal City Marriott at Reagan
National Airport, 1999 Jefferson David
Highway, Arlington, VA 22202.
Contact Person: Linda K Bass, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research and
Training, Nat’l Institute Environmental
Health Sciences, P.O. Box 12233, MD EC–30,
Research Triangle Park, NC 27709, (919) 541–
1307.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel, Cell Differentiation Assays.
Date: May 15, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Chapel Hill, One Europa
Drive, Chapel Hill, NC 27517.
Contact Person: Sally Eckert-Tilotta, Ph.D.,
Scientific Review Officer, Nat. Institute of
Environmental Health Sciences, Office of
Program Operations, Scientific Review
Branch, P.O. Box 12233, Research Triangle
VerDate Sep<11>2014
18:07 Apr 20, 2015
Jkt 235001
Park, NC 27709, (919) 541–1446 eckertt1@
niehs.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Dated: April 15, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–09061 Filed 4–20–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; Prostate, Lung, Colorectal
and Ovarian Cancer Screening Trial
(PLCO) (NCI)
In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Cancer Institute (NCI),
National Institutes of Health (NIH), will
publish periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
Written comments and/or suggestions
from the public and affected agencies
are invited on one or more of the
following points: (1) Whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
SUMMARY:
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
22211
technological collection techniques or
other forms of information technology.
To Submit Comments and for Further
Information: To obtain a copy of the
data collection plans and instruments,
submit comments in writing, or request
more information on the proposed
project, contact: Kelly Yu, Ph.D.,
Division of Cancer Prevention, 9609
Medical Center Drive, Room 5E230,
Rockville, MD 20850 or call non-tollfree number 240–276–7041 or Email
your request, including your address to:
yuke@mail.nih.gov. Formal requests for
additional plans and instruments must
be requested in writing.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Proposed Collection: Prostate, Lung,
Colorectal, and Ovarian Cancer
Screening Trial (PLCO), 0925–0407,
Extension, National Cancer Institute
(NCI), National Institutes of Health
(NIH).
Need and Use of Information
Collection: This is a request for a
revision of the Prostate, Lung, Colorectal
and Ovarian Cancer Screening Trial
(PLCO). This trial was designed to
determine if cancer screening for
prostate, lung, colorectal, and ovarian
cancer can reduce mortality from these
cancers which caused an estimated
253,320 deaths in the U.S. in 2014. The
design is a two-armed randomized trial
of men and women aged 55 to 74 at
entry. OMB first approved this study in
1993 and has approved it every 3 years
since then. Recruitment was completed
in 2001, baseline cancer screening was
completed in 2006, and data collection
continues on the current cohort of
77,281 participants who are actively
being followed. The additional followup will provide data that will clarify
further the long term effects of the
screening on cancer incidence and
mortality for the four targeted cancers.
Further, demographic and risk factor
information may be used to analyze the
differential effectiveness of cancer
screening in high versus low risk
individuals.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
26,320.
E:\FR\FM\21APN1.SGM
21APN1
]]>Agencies
[Federal Register Volume 80, Number 76 (Tuesday, April 21, 2015)]
[Notices]
[Pages 22210-22211]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-09089]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request; Assessing an
Online Process To Study the Prevalence of Drugged Driving in the U.S.:
Development of the Drugged Driving Reporting System (NIDA)
SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National Institutes of Health (NIH) has
submitted to the Office of Management and Budget (OMB) a request for
review and approval of the information collection listed below. This
proposed information collection was previously published in the Federal
Register on November 24, 2014, page 69864 and allowed 60 days for
public comment. No public comments were received. The purpose of this
notice is to allow an additional 30 days for public comment. The
National Institute on Drug Abuse (NIDA), the National Institutes of
Health, may not conduct or sponsor, and the respondent is not required
to respond to, an information collection that has been extended,
revised, or implemented on or after October 1, 1995, unless it displays
a currently valid OMB control number.
Direct Comments to OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burden and associated response time, should be
directed to the: Office of Management and Budget, Office of Regulatory
Affairs, OIRA_submission@omb.eop.gov or by fax to 202-395-6974,
Attention: NIH Desk Officer.
Comments Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30-days
of the date of this publication.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact the NIDA Contract Officer's Representative (COR)
Harold Perl, Ph.D., Chief, Prevention Research Branch, Division of
Epidemiology, Services & Prevention Research, NIDA, 6001 Executive
Blvd., Rockville, MD 20852 or call this non-toll-free number (301) 443-
6504 or email your request, including your address to:
hperl@nida.nih.gov. Formal requests for additional plans and
instruments must be requested in writing.
Proposed Collection: Assessing an Online Process to Study the
Prevalence of Drugged Driving in the U.S: Development of the Drugged
Driving Reporting System, 0925-New, National Institute on Drug Abuse
(NIDA), National Institutes of Health (NIH).
Need and Use of Information Collection: The study seeks to provide
an improved understanding of the prevalence of drugged driving among
adult drivers in the U.S and will assess the effectiveness of the
online survey implementation process. The primary objectives of the
study are to: (a) To provide comprehensive data on drugged driving; (b)
determine if the Drugged Driving Survey Instrument (DDS) is an
effective and accurate measure of drugged driving among licensed U.S.
Drivers aged 18 and older. and, (c) to assess the effectiveness of the
survey implementation process, including various levels of incentives
for participation to determine the appropriate/optimal incentive amount
needed to obtain the desired number of total survey respondents within
the timeframe within which survey data will be collected. The findings
will provide valuable information concerning various aspects of
substance use and driving behavior, including: (1) Demographic
information about drivers who do and do not drive while impaired by
medication and/or drugs (e.g. age, zip code, type of driver's license);
(2) which drugs/medications are most likely to be used while driving;
(3) drivers' beliefs and attitudes toward drugged driving.
OMB approval is requested for 2 years. There are no costs to
respondents other than their time. The total annualized estimated
burden hours are 750.
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Average burden
Form name Type of respondent Number of responses per per response Total annual
respondents respondent (in hours) burden hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Drugged Driving Survey.......................... Adults............................ 3,750 1 12/60 750
--------------------------------------------------------------------------------------------------------------------------------------------------------
[[Page 22211]]
Dated: April 14, 2015.
Genevieve deAlmeida,
Project Clearance Liaison, National Institute on Drug Abuse.
[FR Doc. 2015-09089 Filed 4-20-15; 8:45 am]
BILLING CODE 4140-01-P
